Skip to main content
Clinical Trials/NCT02163369
NCT02163369
Unknown
Not Applicable

The Use of Aromatherapy for Symptom Management

Central DuPage Hospital1 site in 1 country40 target enrollmentJuly 2014

Overview

Phase
Not Applicable
Intervention
Peppermint and Lavender Essential Oils
Conditions
Nausea, Vomiting and Anxiety Associated With Medical Oncology Patients
Sponsor
Central DuPage Hospital
Enrollment
40
Locations
1
Primary Endpoint
Post Intervention Patient Interview Form
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this pilot study is to introduce the use of aromatherapy/essential oils to medical oncology patients at Central DuPage Hospital to assess their perceived effectiveness to relieve symptoms of nausea or vomiting and/or anxiety.

Peppermint oil will be used for nausea/vomiting and lavender oil will be used for anxiety. This study will involve administration of aromatherapy to a convenience sample of patients, who will then be asked to complete a brief questionnaire. The questionnaire will involve a simple likert scale to measure efficacy (in the opinion of the patient) and simple multiple-choice questions to determine patients' likeliness to use aromatherapy again.

Registry
clinicaltrials.gov
Start Date
July 2014
End Date
June 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Central DuPage Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult hospitalized medical oncology patients admitted to Central DuPage Hospital.
  • Age 18 years or greater.
  • Able to understand and speak English.
  • Women of non-childbearing potential or with childbearing potential with a negative pregnancy test documented during the hospital stay.
  • Able to understand concept of aromatherapy for treatment of distressing symptoms.

Exclusion Criteria

  • Prisoners.
  • Non-English speaking patients.
  • Under the age of
  • Unable to comprehend the concept of aromatherapy.
  • Severe cognitive impairment.
  • Not experiencing the symptoms of nausea, vomiting or anxiety.
  • Women with child-bearing potential who have not had a negative pregnancy test during the hospital stay.
  • Patients with known allergy to lavender or peppermint.

Arms & Interventions

Peppermint and Lavender Essential Oils

Intervention: Peppermint and Lavender Essential Oils

Outcomes

Primary Outcomes

Post Intervention Patient Interview Form

Time Frame: 24hrs post aromatherapy

Study Sites (1)

Loading locations...

Similar Trials